life in Biological Technology
Navigation Links
life in Biological Technology
Advanced Life Sciences to Host 2009 Second Quarter Financial Results Conference Call and Webcast
CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), announced today that it will host a conference call and webcast discussing the Company's 2009 second quarter results on Tuesday, August 11, 2009 at 10:00 a.m. (EDT). Michael T. Fla...SK Life Sciences has Licensed Pristima
Xybion Medical Systems, is pleased to announce that SK Life Science, Inc. (SKLSI), has licensed Pristima for its Research and Development facility in Fair Lawn, New Jersey. Cedar Knolls, NJ (PRWEB) August 3, 2009 -- Xybion Medical Systems, a world leader in toxicology a...CHICAGO, July 31 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced that it received a complete response letter today from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Restanza(TM) (cethrom...
Caliper Life Sciences Reports Second Quarter 2009 Results
HOPKINTON, Mass., July 30 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today reported that for the second quarter of 2009 revenues were $32.1 million compared to $34.0 million for the second quarter of 2008. Divestitures and foreign currency translation negati...Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of George F. Horner III of Sofinnova Ventures and Harry T. Rein of Foundation Medical Partners to its Board...NEWARK, N.J., July 21 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology based Life Science Company announced today that at ATS Labs using the required EPA protocol testing, BioNeutral's Ygiene(TM) Hospital Grade Antimic...
Caliper Life Sciences' Second Quarter 2009 Financial Results Conference Call Notice
HOPKINTON, Mass., July 16 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) will conduct a conference call discussing the company's second quarter 2009 financial results at 9:00 a.m. ET on Thursday, July 30. Kevin Hrusovsky, President and Chief Executive Officer an...NEWARK, N.J., July 13 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology-based Life Science company announced today that at ATS Labs using the EPA required AOAC Sporicidal Test, the Hospital Grade of its Ygiene(TM) ...
How much is life worth? The $440 billion question
The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S. that needs to be addressed by the oncology community, according to a commentary published online June 29 in the Journal of the National Canc...- Caliper Addresses Key Bottlenecks in Quality by Design Initiative for Protein Therapeutics - HOPKINTON, Mass., June 29 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today launched the Staccato Protein W...
Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study
CHICAGO, June 23 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced that a second non-human primate study involving its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day course of Restanza achieved a 100% su...First and only Web-based solution for managing compliance and regulated content throughout the product lifecycle reduces costs, risk, and time-to-market SAN DIEGO, June 22 /PRNewswire/ -- Drug Information Association 45th Annual Meeting -- Virtify, Inc. , the market leader in enterpr...
OpenQ is Awarded Prestigious Life Sciences Industry Award
OpenQ wins the 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year presented by Frost & Sullivan Charlottesville, VA, New York, NY and Paris, France (PRWEB) June 15, 2009 -- OpenQ, one of the industry leaders in KOL management solutions and MSL per...AMSTERDAM, June 12 /PRNewswire/ -- - Improving Research Discoverability and Productivity Elsevier today announced a new partnership agreement with NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked wit...
Sigma-Aldrich Introduces New Services Network Complementing Its Life Sciences Product Portfolio
Customers can now conveniently access a collection of support services that can be used on a short or long term basis to accelerate their research ST. LOUIS, June 9 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced the launch of its new Services Network desig...Caliper Life Sciences to Webcast Investor Session of Open House
HOPKINTON, Mass., June 8 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced that it will hold a Customer and Investor Open House entitled, "Innovation for Experimentation" to be held June 17, 2009 at Caliper's Hopkinton headquarters. The company will webcast t...Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
SUNNYVALE, Calif., June 5 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated disease and cancer, today announced that Glenn Rice, President and C...Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at...Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
SAN DIEGO, June 5, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that the company is scheduled to present at the 8th Annual Needham Life Sciences Conference on June 11, 2009 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the New York Palace ...Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
LIVE AUDIO WEBCAST WEDNESDAY, JUNE 10, 2009 SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the 8th Annual Needham Life Sciences...Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
RICHMOND, Calif., June 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(TM) development programs and an overview of the company's business s...NeurogesX to Present at Needham Life Sciences Conference
SAN MATEO, Calif., June 3 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at th...VIVUS to Present at the Needham and Company Life Sciences Conference
MOUNTAIN VIEW, Calif., June 3 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS ), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Dr. Barbara Troupin, senior director clinical development, will present an overview...Multifaceted agreement enhances Microsoft Amalga Life Sciences to accelerate basic research and drive personalized medicine. REDMOND, Wash., June 1 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that it has signed an agreement with Merck & Co. Inc. to acquire certain assets of ...
KVISTGAARD, Denmark, June 1 /PRNewswire-FirstCall/ -- Detailed data from a randomized Phase 2 study with PROSTVAC(TM) were presented Saturday at the ASCO Annual Meeting in Orlando. The presentation was made by Philip Kantoff MD, Professor of Medicine, Harvard Medical School , and the Dana-Far...
GRAND RAPIDS, Mich., May 20 /PRNewswire/ -- The West Michigan Science & Technology Initiative today announced that it has been selected to review and approve applications from life science companies for micro-loans through the Michigan Pre-Seed Capital Fund. The Michigan Pre-Seed Capital Fund...
Reprints NRx for the Force.com AppExchange saves time for reprint buyers by integrating the quote and order initiation process from within Salesforce CRM Santa Monica, Calif. (PRWEB) May 19, 2009 -- Reprints Desk, Inc., the content workflow company, today announced the ...
Reprints NRx for the Force.com AppExchange saves time for reprint buyers by integrating the quote and order initiation process from within Salesforce CRM SANTA MONICA, Calif., May 19 /PRNewswire/ -- Reprints Desk, Inc., the content workflow company, today announced the availability of Repri...
Venture Capitalists to Invest in Promising PA Life Science Companies, Governor Rendell Says
Pittsburgh & Philadelphia Firms to Help Stimulate Biotech Sector HARRISBURG, Pa., May 14 /PRNewswire-USNewswire/ -- Pennsylvania is setting the stage for future opportunity and innovation while expanding its reputation as a leader in the life science industry, Governor Edward G...Advanced Life Sciences Common Stock Begins Trading on OTC Bulletin Board
- Company to Host 2009 First Quarter Financial Results Conference Call and Webcast - CHICAGO, May 6 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. announced today that its common stock is eligible for quotation and trading on the Over-the-Counter Bulletin Board (OTCBB) under ...Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients
New Study Published in the Journal of Rheumatology Examines Quality of Life and Disability in Treatment Failure Gout Patients EAST BRUNSWICK, N.J., May 5 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today the print publication of the Savient-supported lo...Attendees Learn Latest Advancements, from Medical Records Management to Bioterrorism Preparedness. Culver City, CA (PRWEB) May 5, 2009 -- SemTech 2009, the fifth annual Semantic Technology Conference and leading forum on real-world commercial, strategic, and future appl...
Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company
BOSTON, May 4 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment bank, is pleased to announce that John L. Brooks, III has joined the firm as senior advisor. In this role, Mr. Brooks will participate with the firm on internal and client-related activities ...Caliper Life Sciences Reports First Quarter 2009 Results
- 11% Organic Revenue Growth Driven by Microfluidics and Imaging - - Net Loss Narrowed by $0.07 per Share - HOPKINTON, Mass., April 30 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today reported its first quarter financial results for 2009. First quarter reven...Bio Career Center Becomes Top in Nation for Life Sciences Careers
More listings for life science postgraduates than any other U.S. jobs board SANTA CRUZ, Calif., April 28 /PRNewswire/ -- Bio Career Center has become the nation's number one jobs board for post-graduate careers in the life sciences. The jobs board, www.biocareercenter.com , is only fo...LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
SALEM, Mass., April 27 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected as investor relations agency of record for Pegasus Biologics, Inc. Donna L. LaVoie, President & CEO of LaVoie Group, commented, "Pegasus ...-Testimony To Legislature Calls For Rejection Of Legislation That Will Cost Vermonters Current And Future Jobs- MONTPELIER, Vt., April 24 /PRNewswire/ -- In testimony to the Legislature and a full page ad in today's Rutland Herald, the region's largest biotechnology association warned that a ...
Isilon Hosts Industry Leaders Panel on the Future of Life Sciences and IT at Bio-IT World 2009
Dr. George Church of the Personal Genome Project and Matthew Trunnell of The Broad Institute Among Industry Leaders Discussing Impact of IT on Next Generation of Life Sciences Research SEATTLE, April 24 /PRNewswire-FirstCall/ -- Isilon(R) Systems (Nasdaq: ISLN ), the proven leader in sc...NEW YORK, April 23 /PRNewswire/ -- Government and private insurers are placing unprecedented pressures on Life Sciences companies to demonstrate value for the products they develop, according to The 2009 Ernst & Young business risk report, Life sciences. Insurers, governments and individuals a...
OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ), announced today that it has been named the 2009 Life Sciences Company of the Year by LifeSciences British Columbia. This annual award is presented by LifeS...Other TagsInstrumentInstrumentInstrumentInstrumentDelayedGreenerProtestDeveloperRespiteBatteryOther Contentsstreptococcalstreptococcalstreptococcalstridorstrokestrokestrokestrokestrokestrokestyehematomastrokesstrokesstrokesstrokesstrokes
MurdererAhmedabadInstrumentZagrebMurderedMotivationDelayedGreenerProtestCycloneDeveloperMetforminRespiteBattery
(Date:12/4/2009)... by physicians and scientists to study brain function and ... unknown whether the electrodes on the head give an ... Scientists at the Max Planck Institute for Biological Cybernetics ... between the activity generated within the brain to that ...
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... biometric identification solutions, announced that a majority of ... today approved the sale of the company,s Law ... the shares voted, 98.6% were cast in favor ...
(Date:12/3/2009)... that repels grime and dirt? Expanded battery storage capacities ... research, just published in Nature Nanotechnology , details ... that could make these futuristic visions come true in ... of 100 nanometers (roughly one-billionth of a meter) and ...
Breaking Biology News(10 mins):How to read brain activity? 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 1BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 2BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 3Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010 5587 1Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010 5587 2WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 1WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 2WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 3(Date:12/7/2009)... Today the Centers for Disease Control and Prevention (CDC) ... the week was designed to highlight the importance of ... of taking additional steps to keep you and your ... of December, January and beyond. ,, "It,s easy to ... topic of both seasonal and swine flu," said Dr. ...
(Date:12/6/2009)... BROOK, Ill., Dec. 7 The University ... (AMC) members for their achievements in UHC,s Supply ... organizations are noted for modeling best practices in ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined ... that includes contract portfolio participation and use of ...
(Date:12/6/2009)... future treatments targeting growth factor, researchers say , , ... breast cancer cells from the main tumor to other ... factor known as TGFb, which may prove a promising ... British researchers say. , Previous studies have shown that ... and movement. In this new study, a team from ...
(Date:12/6/2009)... Dec. 6 Blood clotting, or coagulation, ... when a blood vessel is injured. Sometimes, however, ... an obvious injury or do not dissolve naturally, ... today at the 51st Annual Meeting of the ... of using the anticoagulants aspirin and heparin with ...
(Date:12/5/2009)... shown in a phase 1/2 clinical trial that ... of patients newly diagnosed with multiple myeloma, a cancer ... from Dana-Farber Cancer Institute. , Partial responses or better ... with the drug combination in the multi-center study, with ... in the phase 2 population, reports Paul G. Richardson, ...
Breaking Medicine News(10 mins):Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2[1] As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu[1] Recognized Top Performers in UHC Supply Chain[1] Breast Cancer's Spread Now Better Understood[1] Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages[0] Multiple myeloma patients experience high response rate with new 3-drug combination
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |